Cargando…
Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
In this study, we probed the importance of O-GlcNAc transferase (OGT) activity for the survival of tamoxifen-sensitive (TamS) and tamoxifen-resistant (TamR) breast cancer cells. Tamoxifen is an antagonist of estrogen receptor (ERα), a transcription factor expressed in over 50% of breast cancers. ERα...
Autores principales: | Barkovskaya, Anna, Seip, Kotryna, Prasmickaite, Lina, Mills, Ian G., Moestue, Siver A., Itkonen, Harri M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552408/ https://www.ncbi.nlm.nih.gov/pubmed/33046784 http://dx.doi.org/10.1038/s41598-020-74083-z |
Ejemplares similares
-
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
por: Barkovskaya, Anna, et al.
Publicado: (2019) -
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
por: Itkonen, Harri M., et al.
Publicado: (2016) -
O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition
por: Gondane, Aishwarya, et al.
Publicado: (2022) -
O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage
por: Gondane, Aishwarya, et al.
Publicado: (2022) -
X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body
por: Olivier-Van Stichelen, Stéphanie, et al.
Publicado: (2014)